Lucentis (ranibizumab) - Roche, Novartis
Clinical effect of intravitreal ranibizumab and laser photocoagulation on diabetic macular edema: a meta-analysis. (PubMed, Front Endocrinol (Lausanne)) - Oct 2, 2026 - "Intravitreal ranibizumab remains superior to laser photocoagulation in improving vision and reducing macular edema in DME, albeit with higher adverse events. These findings support IVR's continued relevance in contemporary practice, particularly where newer anti-vascular endothelial growth factor agents are unavailable." 
Clinical • Journal • Retrospective data • Review • Diabetic Macular Edema • Ophthalmology
http://www.ncbi.nlm.nih.gov/pubmed/42819802
 
Jianmin Wang; Linyu Hu; Qingmin Ma; Yan Li
 
Oct 2, 2026
 
Prev Next